To profile the effects of both APOE genotype and Alzheimer’s disease PRS, our analyses were limited to BDR donors who had undergone neuropathological assessment and had NeuroChip array data (n = 693, Table 1). This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.